Boston Trust Walden Corp Acquires Shares of 506,427 Axcelis Technologies, Inc. (NASDAQ:ACLS)

Boston Trust Walden Corp bought a new position in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 506,427 shares of the semiconductor company's stock, valued at approximately $53,099,000. Boston Trust Walden Corp owned approximately 1.56% of Axcelis Technologies as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of the stock. Reinhart Partners LLC. grew its stake in shares of Axcelis Technologies by 64.1% in the 3rd quarter. Reinhart Partners LLC. now owns 687,608 shares of the semiconductor company's stock valued at $72,096,000 after buying an additional 268,560 shares in the last quarter. Vanguard Group Inc. grew its position in Axcelis Technologies by 6.5% in the first quarter. Vanguard Group Inc. now owns 4,304,516 shares of the semiconductor company's stock worth $480,040,000 after acquiring an additional 263,604 shares in the last quarter. Granite Investment Partners LLC acquired a new position in shares of Axcelis Technologies during the 2nd quarter worth $27,801,000. Boston Partners bought a new position in shares of Axcelis Technologies during the 1st quarter valued at $20,819,000. Finally, Jackson Square Partners LLC lifted its stake in shares of Axcelis Technologies by 49.0% in the 1st quarter. Jackson Square Partners LLC now owns 492,764 shares of the semiconductor company's stock valued at $54,953,000 after purchasing an additional 162,040 shares during the last quarter. Institutional investors and hedge funds own 89.98% of the company's stock.

Insider Buying and Selling

In other Axcelis Technologies news, Director Jorge Titinger sold 6,086 shares of the firm's stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $109.98, for a total value of $669,338.28. Following the completion of the sale, the director now owns 5,891 shares in the company, valued at approximately $647,892.18. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.43% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have commented on ACLS. DA Davidson increased their target price on shares of Axcelis Technologies from $150.00 to $175.00 and gave the stock a "buy" rating in a research report on Monday, July 15th. Bank of America raised their price objective on Axcelis Technologies from $125.00 to $150.00 and gave the company a "neutral" rating in a research note on Wednesday, July 10th. Needham & Company LLC restated a "hold" rating on shares of Axcelis Technologies in a report on Friday, August 2nd. Craig Hallum increased their price target on Axcelis Technologies from $130.00 to $174.00 and gave the company a "buy" rating in a report on Friday, July 12th. Finally, Benchmark reduced their price objective on shares of Axcelis Technologies from $180.00 to $175.00 and set a "buy" rating for the company in a research note on Friday, August 2nd. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, Axcelis Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $167.33.

Axcelis Technologies Stock Performance

Shares of ACLS stock traded down $0.04 during trading hours on Friday, reaching $89.89. 552,976 shares of the company's stock were exchanged, compared to its average volume of 627,850. Axcelis Technologies, Inc. has a fifty-two week low of $88.89 and a fifty-two week high of $158.61. The company has a quick ratio of 3.26, a current ratio of 4.42 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $2.92 billion, a P/E ratio of 11.87, a P/E/G ratio of 3.02 and a beta of 1.58. The business has a fifty day moving average price of $101.76 and a 200-day moving average price of $114.24.

Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last announced its earnings results on Wednesday, July 31st. The semiconductor company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.18. The business had revenue of $256.51 million for the quarter, compared to analyst estimates of $250.06 million. Axcelis Technologies had a net margin of 21.54% and a return on equity of 27.35%. Axcelis Technologies's revenue was down 6.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.86 earnings per share. Analysts predict that Axcelis Technologies, Inc. will post 6.05 EPS for the current fiscal year.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.